JAK2 V617F: implications for thrombosis in myeloproliferative diseases.

@article{Hexner2007JAK2VI,
  title={JAK2 V617F: implications for thrombosis in myeloproliferative diseases.},
  author={Elizabeth O Hexner},
  journal={Current opinion in hematology},
  year={2007},
  volume={14 5},
  pages={450-4}
}
PURPOSE OF REVIEW A major cause of morbidity in myeloproliferative disorders is thrombosis, although the pathophysiology of this process remains poorly understood. The review will explore the relationship between thrombosis and the recently identified gain-of-function mutation in Janus kinase 2, found in the majority of patients with myeloproliferative… CONTINUE READING